Critical Illness Definitions: Canada's Fine Print

In December 2024, the Canadian Life and Health Insurance Association rewrote 11 of the 26 benchmark critical illness definitions it publishes for the industry, including the wording for cancer, heart attack and stroke (CLHIA Critical Illness Benchmark Definitions, December 2024). The previous update was October 2018. So two neighbours in Burnaby can both own "critical illness insurance," both be diagnosed with the same condition, and get two different answers, because their contracts were written from different versions of the same reference document.

That's the part nobody explains at the kitchen table. Critical illness insurance doesn't pay on the diagnosis your cardiologist gives you. It pays on a diagnosis that satisfies a contract. More than 2 million Canadians have critical illness protection through individual or group plans, according to CLHIA (news release, February 22, 2024). Far fewer have read the definitions attached to it.

Who writes critical illness definitions, and who doesn't

Here's the first thing worth knowing. There is no government-mandated list of covered conditions in Canada. CLHIA publishes a set of benchmark definitions, and the 2024 document states plainly that "Use of the definitions is completely voluntary and member companies may make their own determination as to which definition(s) they decide to use in their contracts."

So the benchmark is a common vocabulary, not a rulebook. Some insurers adopt it word for word. Some adopt most of it. Some write their own. That's why comparing contracts matters, and it's much of what an independent broker is doing when they put several insurers side by side for a family in New Westminster or Coquitlam.

The survival period: 30 days, and what that clock really measures

The 2024 benchmark document is direct about this: "All contracts should have a Survival Period." It then defines it as "the period starting on the Date of Diagnosis of the Critical Condition and ending 30 days later, except where modified elsewhere under the policy."

Three details inside that sentence do a lot of work:

• The clock starts at diagnosis, not at treatment. And the benchmark notes separately that "The Date of Diagnosis must occur while the policy is in force."
• Days on life support don't count. The definition says the survival period "does not include the number of days on Life Support," and life support is defined as care for nutritional, respiratory or cardiovascular support after irreversible cessation of all brain function.
• You have to be alive and neurologically alive at the end. The wording is that the insured "must be alive and must not have experienced irreversible cessation of all functions of the brain at the end of the Survival Period."
• "Except where modified elsewhere" is not filler. Individual contracts can shorten or lengthen it. Thirty days is the benchmark, not a law.

Why 30 days? Because critical illness insurance is a living benefit, and the first month after a major cardiac event is genuinely the high-risk window. The Canadian Institute for Health Information tracks a national indicator defined as "The risk-adjusted rate of all-cause in-hospital death occurring within 30 days of first admission with a diagnosis of acute myocardial infarction (AMI)" (CIHI, data updated September 2026, covering fiscal years 2014 to 2025). The insurance industry didn't invent the 30-day window. It borrowed a clinically meaningful one.

The clocks people forget: qualifying periods

The survival period is not the only waiting period in the contract. Several conditions have their own built-in persistence requirements, and the 2024 benchmark is specific about them:

• Stroke requires new objective neurological deficits that "must persist continuously for more than 30 days following the date of diagnosis," corroborated by diagnostic imaging. Transient ischaemic attacks are excluded outright.
• Benign brain tumour requires neurological deficits persisting more than 30 days, unless the insured had surgery, radiation or embolization.
• Bacterial meningitis requires neurological deficits persisting at least 90 days.
• Loss of independent existence requires inability to perform at least 2 of 5 activities of daily living for a continuous period of at least 90 days.
• Coma requires unconsciousness for a continuous period of at least 72 hours with a Glasgow coma score of 6 or less.

The benchmark adds that for conditions with a qualifying period, "the Survival Period runs concurrently with that condition's qualifying period." Good news. They stack in parallel, not end to end.

One more piece of fine print: the benchmark for stroke and bacterial meningitis both say headache or fatigue "will not be considered a neurological deficit." A real, exhausting symptom can still fail the contract test.

Partial payout conditions, and where they actually come from

This is where the honest answer is less tidy than most articles suggest. The CLHIA 2024 benchmark set defines 26 conditions. It says nothing at all about partial payouts, percentages, or early-stage benefits. Not a word. Those features exist entirely at the insurer's discretion, which is why they vary so much.

What the benchmark does give you is the map of where partial benefits tend to live: the early-stage cancers it explicitly carves out of the full cancer definition. Under the 2024 wording, cancer excludes, among others:

• Malignant melanoma of skin 1.0mm or less in thickness that is not ulcerated and has not spread
• Any non-melanoma skin cancer without lymph node or distant metastases
• Prostate cancer unless described as AJCC T2 or higher and/or Gleason grade 7 or higher
• Thyroid cancer unless AJCC T2 or higher, or spread to lymph nodes or other organs
• Chronic lymphocytic leukemia classified as Rai stage 0
• Cancers described as carcinoma in situ, Tis or Ta

Coronary angioplasty is an interesting case. It sits on the benchmark list as its own named condition, defined as a medically necessary interventional procedure to unblock or widen a coronary artery. The benchmark doesn't say what it pays. Some contracts treat conditions like this as reduced benefits, some don't cover them at all, and you can't tell without reading the specific policy. Anyone quoting you a percentage without naming the insurer and the contract version is guessing.

The 90-day exclusion that surprises people most

Read this one twice. The 2024 benchmark cancer definition includes a 90-day exclusion: if within the first 90 days after the policy's effective date (or after reinstatement) the insured "is diagnosed with any cancer or develops signs or symptoms that lead to an eventual cancer diagnosis, we will not pay a benefit for this cancer or for any future cancer diagnosis."

Not just that cancer. Any future cancer diagnosis. The same structure appears in the benign brain tumour definition. It's the single strongest argument for not waiting until something feels off before applying.

Definitions get disputed, and sometimes reversed

The OmbudService for Life and Health Insurance published a case where an insurer denied a claim because a brain tumour, "initially classified as benign, did not meet the policy's definition of a life-threatening cancer." After OLHI escalated it, the insurer's medical consultant reassessed, found the tumour had become aggressive and life-threatening, and reversed the decision and approved the claim.

If your claim is denied, there's a complaints path, and it's free.

What this doesn't tell you

• The benchmark is not your contract. Everything above comes from CLHIA's voluntary 2024 reference document. Your policy may use the 2013 or 2018 wording, or the insurer's own. Only your policy document governs your claim.
• Partial payout amounts aren't standardized. No credible published source gives you an industry-wide percentage, because there isn't one.
• Sources genuinely disagree on typical survival periods. The benchmark says 30 days. Insurer materials describe ranges that vary by condition and by policy, and older reference material cites shorter periods. The range is real, and so is the ambiguity.
• This is educational, not diagnostic. Whether a specific condition qualifies is a medical and contractual question decided on your records, not something anyone can settle from an article.
• No pricing here on purpose. Premiums depend on age, health, smoking status, coverage amount and the contract you choose.

In British Columbia, the person helping you should be licensed by the Insurance Council of BC, which requires the Life Licence Qualification Program plus the Insurance Council Rules Course, and supervision of new agents for at least 24 months. Ask to see the definitions page before you sign anything.

*This article summarises published rules and research for general information, is current as of September 28, 2026, and is not personalized financial, tax or legal advice.*

Sources

• Canadian Life and Health Insurance Association, *Reference Document: Critical Illness Benchmark Definitions (CIBD)*, December 2024. PDF and landing page
• Canadian Life and Health Insurance Association, *Got questions about critical illness insurance? CLHIA's latest consumer guide has answers to help you*, news release, February 22, 2024. Link
• Canadian Institute for Health Information, *30-Day Acute Myocardial Infarction In-Hospital Mortality* indicator, fiscal years 2014 to 2025, data updated September 2026. Link
• OmbudService for Life and Health Insurance (OLHI), *Feeling supported through a critical illness*, case study. Link
• Insurance Council of British Columbia, *Individual Life Insurance Agent Licence*. Link

If you'd like someone to read your actual policy wording with you, side by side with what other Canadian insurers offer, book a free no-pressure call with Milo. He's an independent broker in Burnaby, he works with families across Metro Vancouver, and he speaks English and Tagalog. No sales pitch, just a clear look at what your contract says and whether it still fits your family.